Molecular Pathology in the Context of Lung Cancer

The development of lung cancer targeted therapies has given a privileged place for molecular pathology, which plays a crucial role in cancer diagnosis and in the identification of tumor biomarkers. An increasing number of biomarkers are essential for the initial diagnosis and treatment decision making of patients with lung cancer.